Our first edition features Sabine Vogler, the Head of the Pharmacoeconomics Department at Gesundheit Österreich GmbH. Sabine guides us through the key findings of the Hub-commissioned report on what tools national health systems have at their disposal to further reward the development and uptake of much needed new antibiotics and diagnostics (published in March 2021). Enjoy!
National Health System Tools to Improve Valuation
What tools do National health systems have at their disposal to further reward the development and uptake of much needed new antibiotics and diagnostics? Undertaken by the team at the Austrian Institute of Public Health (GÖG), the Global AMR R&D Hub is happy to publicly-release this important study today. This comprehensive review of available policy tools within pricing, reimbursement and procurement in ten G20 countries, includes concrete examples and suggestions for learning, leverage and implementation. This is one of three studies that were used to derive our recently-published recommendations put forward to the G7 and G20 for their ongoing reflections.
